Page last updated: 2024-08-24

3-iodobenzylguanidine and everolimus

3-iodobenzylguanidine has been researched along with everolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Del Rivero, J; Ilanchezhian, M; Jha, A; Pacak, K	1

Reviews

1 review(s) available for 3-iodobenzylguanidine and everolimus

Article	Year
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma. Current treatment options in oncology, 2020, 08-29, Volume: 21, Issue:11 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytoreduction Surgical Procedures; Dacarbazine; Everolimus; Humans; Liver Neoplasms; Lung Neoplasms; Octreotide; Paraganglioma; Pheochromocytoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiopharmaceuticals; Surgical Procedures, Operative; Vincristine	2020

Article

Year

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.

Current treatment options in oncology, 2020, 08-29, Volume: 21, Issue:11

Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytoreduction Surgical Procedures; Dacarbazine; Everolimus; Humans; Liver Neoplasms; Lung Neoplasms; Octreotide; Paraganglioma; Pheochromocytoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiopharmaceuticals; Surgical Procedures, Operative; Vincristine

2020